NEWS
View news from our Featured Companies.
LiqTech Receives System Order for Oil & Gas MEG Recovery
BALLERUP, Denmark, Dec. 2, 2022 -- LiqTech International, Inc. (NASDAQ: LIQT), a clean technology company that manufactures and markets highly specialized filtration products and systems, today announced the receipt of a $0.5 million order for a complete filtration...
Aytu BioPharma Announces Highest Weekly Adzenys XR-ODT® Prescriptions Generated Since Inception of RxConnect
Adzenys XR-ODT Total Prescription (TRx) Unit Growth Driven by a Combination of Continued Sales Force Execution, Leveraging of the Aytu RxConnect Patient Support Program, and a Positive Response to the Adderall® XR Supply DisruptionAdzenys XR-ODT is the Only...
Jewett-Cameron Announces Fiscal 2022 Financial Results
NORTH PLAINS, Ore., Nov. 29, 2022 -- Jewett-Cameron Trading Company Ltd. (NASDAQ: JCTCF) today reported financial results for its fourth quarter and fiscal year ended August 31, 2022. For the fiscal year ended August 31, 2022, Jewett-Cameron had sales of $62.9 million...
Scientific Industries Launches New VIVID® LITE Automated Pill Counter
VIVID LITE provides pharmacists access to affordable state-of-the-art automated pill counting productBOHEMIA, NY / November 29, 2022 / Scientific Industries, Inc. (OTCQB:SCND), a life sciences tool provider and a developer of digitally simplified products, today...
PolyPid Announces Presentation of Phase 2 D-PLEX Clinical Data at the First Triennial Meeting of the International Orthopaedic Trauma Association
D-PLEX Infection Prevention Efficacy in Patients with Increased Risk for Surgical Wound Infections Including Multi-Drug Resistant Organisms (MDROs) will be Presented During a Podium PresentationPETACH TIKVA, Israel, Nov. 29, 2022 -- PolyPid Ltd. (Nasdaq: PYPD)...
Zoomd Technologies Reports Third Quarter 2022 Financial Results.
Conference call will be held on November 29, 2022 at 11AM ET. VANCOUVER, British Columbia, Nov. 29, 2022 -- Zoomd Technologies Ltd. (TSXV: ZOMD) (OTC: ZMDTF) and its wholly-owned subsidiary Zoomd Ltd. (collectively, "Zoomd" or the "Company"), the marketing technology...
ARIANNE PHOSPHATE APPOINTS DR. RAEF SULLY TO THE COMPANY
-former Nutrien Ltd. CEO of Nitrogen & Phosphate to act as a strategic advisor DAN: TSX-V (Canada)JE9N: FSE (Germany)DRRSF: OTC (USA) SAGUENAY, QC, Nov. 29, 2022 /CNW Telbec/ - Arianne Phosphate (the "Company" or "Arianne") (TSXV: DAN) (OTC: DRRSF) (FRANKFURT:...
Modular Medical Announces Product Testing Update
SAN DIEGO, CA / November 28, 2022 / Modular Medical, Inc. (the "Company" or "Modular Medical") (NASDAQ:MODD), a development stage, insulin delivery technology company seeking to launch the next generation of easy to use and affordable insulin pump technology, today...
Modular Medical Announces Participation at Upcoming Investor Conferences
SAN DIEGO, CA / November 23, 2022 / Modular Medical, Inc. (the "Company" or "Modular Medical") (NASDAQ:MODD), a development stage, insulin delivery technology company seeking to launch the next generation of easy to use and affordable insulin pump technology, today...
ARIANNE PHOSPHATE REPORTS CORPORATE AND FINANCIAL RESULTS FOR THIRD QUARTER 2022
DAN: TSX-V (Canada)JE9N: FSE (Germany)DRRSF: OTC (USA) SAGUENAY, QC, Nov. 22, 2022 /CNW Telbec/ - Arianne Phosphate (the "Company" or "Arianne") (TSXV: DAN) (OTC: DRRSF) (FRANKFURT: JE9N) a development-stage phosphate mining company, advancing its Lac à Paul...
Aytu BioPharma Receives a 180-Day Extension by Nasdaq to Regain Compliance with Bid Price Rule
ENGLEWOOD, CO / November 22, 2022 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a commercial stage pharmaceutical and consumer health company providing pediatric-focused prescription drugs and cost-effective consumer health solutions, announced today...
Zoomd to Report Third Quarter 2022 Financial Results on November 29, 2022
Conference call to be conducted on November 29, 2022 at 11 a.m. ET. VANCOUVER, BC, Nov. 22, 2022 -- Zoomd Technologies Ltd. (TSXV: ZOMD) (OTC: ZMDTF) and its wholly-owned subsidiary Zoomd Ltd. (collectively, "Zoomd" or the "Company"), the marketing technology...
ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2022
PORTLAND, Maine, Nov. 21, 2022 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
Reviva Pharmaceuticals Announces Canadian Composition of Matter Patent for Triple Reuptake Inhibitor RP1208
- RP1208 is in preclinical development for the potential treatment of depression and obesity - - Composition of matter patents for RP1208 have been granted in key markets around the world including the United States, Europe, China, and Japan - CUPERTINO, Calif., Nov....
SenesTech, Inc. Announces Closing of $5 Million Public Offering
PHOENIX, Nov. 18, 2022 -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company") (www.senestech.com) the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats, ContraPest®, today announced the...
Kiora Pharmaceuticals Enters Into Agreements to Raise $3.12 Million From the Exercise of Previously Issued Class A Warrants
Salt Lake City, Utah--(November 18, 2022) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) ("Kiora" or the "Company") announced today it has entered into warrant inducement offer letters to raise $3.12 million in gross proceeds from the exercise of 654,609 Class A...
Aytu BioPharma Ranked Among Fastest-Growing Companies in North America on Deloitte’s Technology Fast 500™ for Second Year in a Row
Ranked 94th Fastest Growing Company in North AmericaRanked 21st Fastest Growing Life Sciences CompanyENGLEWOOD, CO / November 17, 2022 / Aytu BioPharma, Inc. (the Company or "Aytu") (NASDAQ:AYTU), a commercial stage pharmaceutical and consumer health company providing...
Kiora Pharmaceuticals Doses First Patient in ABACUS Phase 1b Study Evaluating KIO-301 for Retinitis Pigmentosa
Salt Lake City, Utah--(November 17, 2022) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) ("Kiora" or the "Company") announced today the dosing of the first patient in a first-in-human open-label clinical trial for KIO-301, intended to restore vision loss in patients...
SenesTech, Inc. Announces Pricing of $5 Million Public Offering
PHOENIX, Nov. 16, 2022 -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company") (www.senestech.com) the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats, ContraPest®, today announced the...
Aytu BioPharma Announces the Passing of Co-Founder and Board Member Michael Macaluso
ENGLEWOOD, CO / November 16, 2022 / Aytu BioPharma, Inc. (the Company or "Aytu") (NASDAQ:AYTU), a commercial stage pharmaceutical and consumer health company providing pediatric-focused prescription drugs and cost-effective consumer health solutions, announced the...
SenesTech Announces Reverse Stock Split
Common Stock Will Begin Trading on a Split-Adjusted Basis on November 16, 2022 PHOENIX, Nov. 15, 2022 -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company") (www.senestech.com) the rodent fertility control experts and inventors of the only EPA registered...
Shuttle Pharmaceuticals Provides Third Quarter 2022 Corporate Update
ROCKVILLE, Md., Nov. 15, 2022 -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH), a discovery and development stage specialty pharmaceutical company focused on improving the outcomes of cancer patients treated with radiation therapy (RT), today provided a...
Precision Optics to Uplist to the Nasdaq Capital Market
Trading Under the Ticker "POCI" Expected to Begin on Wednesday, November 16, 2022 GARDNER, Mass., Nov. 15, 2022 -- Precision Optics Corporation, Inc. (OTCQB: PEYE; PEYED) (NASDAQ: POCI) (the "Company") today announced that the Company has been approved to list on the...
Scientific Industries Reports First Quarter Fiscal Year 2023 Financial Results
Bioprocessing and VIVID Product Sales Increase SignificantlyBOHEMIA, NY / November 15, 2022 / Scientific Industries, Inc. (OTCQB:SCND), a life sciences tool provider and a developer of digitally simplified bioprocessing products, yesterday reported financial results...
Reviva Pharmaceuticals Holdings, Inc. Reports Third Quarter 2022 Financial Results and Recent Business Highlights
- Over 30% enrollment in ongoing global, pivotal Phase 3 RECOVER trial - - Topline data for Phase 3 RECOVER trial evaluating brilaroxazine for schizophrenia still expected mid-2023 - - $23.2 Million in Cash as of September 30, 2022 - CUPERTINO, Calif., Nov. 14, 2022...